NCT02256787View on ClinicalTrials.gov

Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2004

Conditions
Healthy
Interventions
DRUG

BILB 1941 ZW - single rising dose part

DRUG

Placebo

DRUG

BILB 1941 ZW - solution

DRUG

BILB 1941 ZW - tablet

OTHER

standardized breakfast

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02256787 - Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food | Biotech Hunter | Biotech Hunter